Workflow
BillionToOne(BLLN)
icon
Search documents
美国 IPO 市场本周动态:多领域企业密集上市,SPAC与微型股成亮点
美股研究社· 2025-10-11 09:31
Core Insights - The U.S. IPO market remains active despite government shutdown, with 6 traditional IPOs and 2 SPACs launched this week, alongside 13 companies filing for initial public offerings [1][12]. Group 1: IPO Activity - Alliance Laundry Holdings (ALH) raised $826 million, pricing at the upper limit of its range, achieving a market cap of $4.5 billion, and saw a 14% stock price increase [1]. - Phoenix Education Partners (PXED) raised $136 million, pricing at the midpoint of its range, with a market cap of $1.3 billion and a 13% stock price increase [1]. - Ping An Good Doctor (POM) raised $20 million, pricing at the lower limit of its range, with a market cap of $474 million and a 9% stock price increase [2]. - One and One Green Tech (YDDL) raised $10 million, pricing at the midpoint of its range, achieving a market cap of $27 million and a significant 31% stock price increase [2]. - Leifras (LFS) raised $5 million, pricing at the lower limit of its range, with a market cap of $10.5 million, but experienced a 5% stock price decline [2]. - Turn Therapeutics (TTRX) debuted via direct listing at $10, but saw a 26% decline in stock price [3]. Group 2: SPAC Activity - Two SPACs completed their listings: GigCapital8 (GIWWU) raised $220 million and Lake Superior Acquisition (LKSPU) raised $100 million, focusing on energy, social media, and consumer goods [4]. - Five SPACs filed for IPOs, including Xsolla SPAC 1 (XSOLU.RC) and Alussa Energy Acquisition II (ALUBU), both aiming to raise $250 million [8][10]. Group 3: Upcoming IPOs and Market Trends - 13 companies filed for IPOs, including BillionToOne (BLLN), Evommune (EVMN), and Central Bancompany (CBC), each planning to raise $100 million [6]. - The SEC issued new guidelines allowing companies to announce pricing ranges and set final pricing above the range, which may encourage more companies to proceed with listings amid the government shutdown [12].
分子诊断公司BillionToOne(BLLN.US)申请美股IPO 拟筹资1亿美元
智通财经网· 2025-10-09 08:55
智通财经APP获悉,分子诊断公司BillionToOne(专注于基于单分子测序平台开发产前与肿瘤诊断技术)于 周二向美国证券交易委员会(SEC)提交申请,计划通过首次公开发行(IPO)募集至多1亿美元资金。 2023年,公司进一步推出两款互补性泛癌液体活检检测产品:一款是用于指导治疗方案选择的Northstar Select,另一款是基于甲基化技术的Northstar Response——该检测可在单分子水平上量化癌症负荷,且 无需进行组织活检。 这家总部位于美国加利福尼亚州门洛帕克的公司成立于2016年,截至2025年6月30日的12个月内实现营 收2.09亿美元。公司计划在纳斯达克证券交易所上市,股票代码为"BLLN"。此前,BillionToOne已于 2025年6月20日以保密形式提交了IPO申请。此次交易的联席账簿管理人包括摩根大通、派珀·桑德勒 (Piper Sandler)、杰富瑞、威廉·布莱尔(William Blair)、斯蒂费尔(Stifel)、富国证券及BTIG。目前,公司 尚未披露IPO定价相关条款。 BillionToOne聚焦分子诊断领域,依托其单分子下一代测序(smNGS)平台开 ...